Natural ligand of G protein coupled receptor RCC356 and uses thereof

Details for Australian Patent Application No. 2006222265 (hide)

Owner Chemcom S.A.

Inventors Veithen, Alex; Philippeau, Magali; Sallmann, Frederic

Agent Shelston IP

Pub. Number AU-B-2006222265

PCT Pub. Number WO2006/094704

Priority 05447046.3 03.03.05 EP

Filing date 2 March 2006

Wipo publication date 14 September 2006

Acceptance publication date 5 July 2012

International Classifications

G01N 33/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

A61K 31/19

A61K 38/00 Medicinal preparations containing peptides

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/00 Drugs for disorders of the nervous system

A61P 35/00 Antineoplastic agents

C07K 16/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/094704 Priority application(s): WO2006/094704

27 September 2007 Amendment Made

  The nature of the amendment is: Amend the name of the co-inventor to read Sallmann, Frederic 2007

5 July 2012 Application Accepted

  Published as AU-B-2006222265

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222266-Ophthalmic uses of S1P receptor modulators

2006222252-Pyrazine -2-carboxamide derivatives as mGluR5 antagonists